Form 4 for ISRG Intuitive Surgical
Accepted 2024-01-29 00:00:00 ET · period of report 2024-01-26 · accession 0001035267-24-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-29 | 2024-01-26 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $179.67 | +4,318 | 1,689 | New | +$775.8K |
| DM | 2024-01-29 | 2024-01-26 | ISRG | Curet Myriam | EVP, Chief Medical Off | S - Sale+OE | $370.15 | -4,318 | 189 | -96% | -$1.60M |
| DM | 2024-01-29 | 2024-01-26 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $0.00 | -4,318 | 7,893 | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-26 | M | A | 2,818 | $177.99 | 3,007 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-26 | S | D | 1,500 | $370.15 | 189 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.45 to $371.65 as follows: 1,100 shares sold at $368.45 to $369.45; 1.800 shares sold at $369.54 to $370.52; and 1,418 shares sold at $370.65 to $371.65. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2024-01-26 | M | A | 1,500 | $182.83 | 1,689 | D | — | — | |
| 4 | Common | Common Stock | 2024-01-26 | S | D | 2,818 | $370.15 | 189 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.45 to $371.65 as follows: 1,100 shares sold at $368.45 to $369.45; 1.800 shares sold at $369.54 to $370.52; and 1,418 shares sold at $370.65 to $371.65. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-01-26 | M | D | 1,500 | $0.00 | 7,500 | D | $182.83 · — to 2029-02-15 | 1,500 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-01-26 | M | D | 2,818 | $0.00 | 7,893 | D | $177.99 · — to 2030-02-28 | 2,818 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |